Skip to content
lifestyle.nextmentors.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Annovis Bio Inc.
Annovis Provides Corporate Updates and Reports Third Quarter 2026 Financial Results
November 13, 2026
Annovis Bio Granted U.S. Patent Covering New Crystalline Form of Buntanetap
November 12, 2026
Annovis Announces Closing of $21.0 Million Public Offering with 24% Contribution from the Board Chairman
November 9, 2026
Annovis Announces Pricing of $21.0 Million Public Offering
November 5, 2026
Annovis Announces Launch of Proposed Public Offering
November 4, 2026
Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
October 30, 2026
Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026
October 29, 2026
Annovis to Attend the CTAD 2026 with Three Presentations
October 22, 2026
Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer’s Disease
September 23, 2026
Annovis to Host Corporate Update Webinar on September 2, 2026
August 25, 2026
1
2
Next Page
→